Table 3.
Distribution of creatinine-adjusted concentrations of urinary arsenic species (iAs, MMA, and DMA) (n = 64)
| Exposure variablesa\Percentileb | Min | 5th | 25th | 50th | 75th | 95th | Max |
|---|---|---|---|---|---|---|---|
| As metabolites (μg g−1 crea) | |||||||
| MMA | 0.06 | 0.08 | 0.19 | 0.40 (1.10)c | 1.67 | 6.14 | 28.5 |
| DMA | 0.07 | 3.09 | 11.27 | 20.73 (14.58) | 29.5 | 70.75 | 129.1 |
| iAs | 0.11 | 0.19 | 0.41 | 0.83 (0.61) | 1.33 | 4.74 | 6.55 |
| tAs | 0.34 | 3.76 | 12.09 | 23.19 (16.29) | 33.29 | 76.02 | 137.5 |
aAbbreviations: iAs represents the sum of As3+ and As5+; MMA: methylarsonic acid; DMA: dimethylarsinic acid; tAs: the sum of iAs, MMA, and DMA; μg g−1 crea: μg per g creatinine
bPregnant women from Maternal Infant cohort in Taiwan (n = 64). Limit of detection for As3+ is 0.09 μg/L, As5+ is 0.05 μg/L, for MMA it is 0.05 μg/L and for DMA it is 0.04 μg/L
cThe values inside parenthesis are the average value of unadjusted arsenic expressed as μg/L